%0 Journal Article
%T Latin American Consensus: Children Born Small for Gestational Age
%A Margaret CS Boguszewski
%A Veronica Mericq
%A Ignacio Bergada
%A Durval Damiani
%A Alicia Belgorosky
%A Peter Gunczler
%A Teresa Ortiz
%A Mauricio Llano
%A Horacio M Domen¨¦
%A Ra¨˛l Calzada-Le¨®n
%A Armando Blanco
%A Margarita Barrientos
%A Patricio Procel
%A Roberto Lanes
%A Orlando Jaramillo
%J BMC Pediatrics
%D 2011
%I BioMed Central
%R 10.1186/1471-2431-11-66
%X SGA is defined as a birth weight and/or birth length greater than 2 standard deviations (SD) below the population reference mean for gestational age. SGA refers to body size and implies length-weight reference data in a geographical population whose ethnicity is known and specific to this group. Ideally, each country/region within Latin America should establish its own standards and make relevant updates. SGA children should be evaluated with standardized measures by trained personnel every 3 months during year 1 and every 6 months during year 2. Those without catch-up growth within the first 6 months of life need further evaluation, as do children whose weight is ˇÜ -2 SD at age 2 years. Growth hormone treatment can begin in SGA children > 2 years with short stature (< -2.0 SD) and a growth velocity < 25th percentile for their age, and should continue until final height (a growth velocity below 2 cm/year or a bone age of > 14 years for girls and > 16 years for boys) is reached. Blood glucose, thyroid function, HbA1c, and insulin-like growth factor-1 (IGF-1) should be monitored once a year. Monitoring insulin changes from baseline and surrogates of insulin sensitivity is essential. Reduced fetal growth followed by excessive postnatal catch-up in height, and particularly in weight, should be closely monitored. In both sexes, gonadal function should be monitored especially during puberty.Children born SGA should be carefully followed by a multidisciplinary group that includes perinatologists, pediatricians, nutritionists, and pediatric endocrinologists since 10% to 15% will continue to have weight and height deficiency through development and may benefit from growth hormone treatment. Standards/guidelines should be developed on a country/region basis throughout Latin America.Low birth weight (< 2500 g) is prevalent in many countries and poses a significant public health problem contributing to a variety of short- and long-term negative effects. While about half of low-
%U http://www.biomedcentral.com/1471-2431/11/66